{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T20:48:19Z","timestamp":1791146899903,"version":"4.1.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,6,9]],"date-time":"2008-06-09T00:00:00Z","timestamp":1212969600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2008,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Accurate evaluation of axillary lymph node (ALN) involvement is mandatory before treatment of primary breast cancer. The aim of this study is to compare preoperative diagnostic accuracy between positron emission tomography\/computed tomography with <jats:sup>18<\/jats:sup>F-fluorodeoxyglucose (<jats:sup>18<\/jats:sup>F-FDG PET\/CT) and axillary ultrasonography (AUS) for detecting ALN metastasis in patients having operable breast cancer, and to assess the clinical management of axillary <jats:sup>18<\/jats:sup>F-FDG PET\/CT for therapeutic indication of sentinel node biopsy (SNB) and preoperative systemic chemotherapy (PSC).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>One hundred eighty-three patients with primary operable breast cancer were recruited. All patients underwent <jats:sup>18<\/jats:sup>F-FDG PET\/CT and AUS followed by SNB and\/or ALN dissection (ALND). Using <jats:sup>18<\/jats:sup>F-FDG PET\/CT, we studied both a visual assessment of <jats:sup>18<\/jats:sup>F-FDG uptake and standardized uptake value (SUV) for axillary staging.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>In a visual assessment of <jats:sup>18<\/jats:sup>F-FDG PET\/CT, the diagnostic accuracy of ALN metastasis was 83% with 58% in sensitivity and 95% in specificity, and when cut-off point of SUV was set at 1.8, sensitivity, specificity, and accuracy were 36, 100, and 79%, respectively. On the other hand, the diagnostic accuracy of AUS was 85% with 54% in sensitivity and 99% in specificity. By the combination of <jats:sup>18<\/jats:sup>F-FDG PET\/CT and AUS to the axilla, the sensitivity, specificity, and accuracy were 64, 94, and 85%, respectively. If either <jats:sup>18<\/jats:sup>F-FDG PET uptake or AUS was positive in allixa, the probability of axillary metastasis was high; 50% (6 of 12) in <jats:sup>18<\/jats:sup>F-FDG PET uptake only, 80% (4 of 5) in AUS positive only, and 100% (28 of 28) in dual positive. By the combination of AUS and <jats:sup>18<\/jats:sup>F-FDG PET\/CT, candidates of SNB were more appropriately selected. The axillary <jats:sup>18<\/jats:sup>F-FDG uptake was correlated with the maximum size and nuclear grade of metastatic foci (p = 0.006 and p = 0.03).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>The diagnostic accuracy of <jats:sup>18<\/jats:sup>F-FDG PET\/CT was shown to be nearly equal to ultrasound, and considering their limited sensitivities, the high radiation exposure by <jats:sup>18<\/jats:sup>F-FDG PET\/CT and also costs of the examination, it is likely that AUS will be more cost-effective in detecting massive axillary tumor burden. However, when we cannot judge the axillary staging using AUS alone, metabolic approach of <jats:sup>18<\/jats:sup>F-FDG PET\/CT for axillary staging would enable us a much more confident diagnosis.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2407-8-165","type":"journal-article","created":{"date-parts":[[2008,6,10]],"date-time":"2008-06-10T06:13:03Z","timestamp":1213078383000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":103,"title":["Utility of 18F-fluoro-deoxyglucose emission tomography\/computed tomography fusion imaging (18F-FDG PET\/CT) in combination with ultrasonography for axillary staging in primary breast cancer"],"prefix":"10.1186","volume":"8","author":[{"given":"Shigeto","family":"Ueda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Tsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Asakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiro","family":"Omata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiko","family":"Fukatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuo","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadaharu","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukihiro","family":"Hama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsumi","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiro","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyuki","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidetaka","family":"Mochizuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,6,9]]},"reference":[{"key":"1103_CR1","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1053\/j.semnuclmed.2004.11.003","volume":"35","author":"JN Aarsvold","year":"2005","unstructured":"Aarsvold JN, Alazraki NP: Update on detection of sentinel lymph nodes in patients with breast cancer. Semin Nucl Med. 2005, 35: 116-128. 10.1053\/j.semnuclmed.2004.11.003.","journal-title":"Semin Nucl Med"},{"key":"1103_CR2","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/BF02967196","volume":"7","author":"K Sato","year":"2000","unstructured":"Sato K, Uematsu M, Saito T, Ishikawa H, Yamasaki T, Tamaki K, Tamai S, Kusano S, Hiraide H, Mochizuki H: Indications and technique of sentinel lymph node biopsy in breast cancer using 99m-technetium labeled tin colloids. Breast Cancer. 2000, 7: 95-98.","journal-title":"Breast Cancer"},{"key":"1103_CR3","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1245\/s10434-006-9106-9","volume":"13","author":"MC van Rijk","year":"2006","unstructured":"van Rijk MC, Teertstra HJ, Peterse JL, Nieweg OE, Olmos RA, Hoefnagel CA, Kroon BB: Ultrasonography and fine-needle aspiration cytology in the preoperative evaluation of melanoma patients eligible for sentinel node biopsy. Ann Surg Oncol. 2006, 13: 1511-1516. 10.1245\/s10434-006-9106-9.","journal-title":"Ann Surg Oncol"},{"key":"1103_CR4","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.amjsurg.2006.02.021","volume":"193","author":"J Nori","year":"2007","unstructured":"Nori J, Vanzi E, Bazzocchi M, Bufalini FN, Distante V, Branconi F, Susini T: Role of axillary ultrasound examination in the selection of breast cancer patients for sentinel node biopsy. Am J Surg. 2007, 193: 16-20. 10.1016\/j.amjsurg.2006.02.021.","journal-title":"Am J Surg"},{"key":"1103_CR5","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.amjsurg.2003.10.012","volume":"187","author":"K Sato","year":"2004","unstructured":"Sato K, Tamaki K, Tsuda H, Kosuda S, Kusano S, Hiraide H, Mochizuki H: Utility of axillary ultrasound examination to select breast cancer patients suited for optimal sentinel node biopsy. Am J Surg. 2004, 187: 679-683. 10.1016\/j.amjsurg.2003.10.012.","journal-title":"Am J Surg"},{"key":"1103_CR6","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1097\/00000658-200211000-00012","volume":"236","author":"JJ van der Hoeven","year":"2002","unstructured":"van der Hoeven JJ, Hoekstra OS, Comans EF, Pijpers R, Boom RP, van Geldere D, Meijer S, Lammertsma AA, Teule GJ: Determinants of diagnostic performance of [F-18]fluorodeoxyglucose positron emission tomography for axillary staging in breast cancer. Ann Surg. 2002, 236: 619-624. 10.1097\/00000658-200211000-00012.","journal-title":"Ann Surg"},{"key":"1103_CR7","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1245\/ASO.2003.12.019","volume":"10","author":"E Barranger","year":"2003","unstructured":"Barranger E, Grahek D, Antoine M, Montravers F, Talbot JN, Uzan S: Evaluation of fluorodeoxyglucose positron emission tomography in the detection of axillary lymph node metastases in patients with early-stage breast cancer. Ann Surg Oncol. 2003, 10: 622-627. 10.1245\/ASO.2003.12.019.","journal-title":"Ann Surg Oncol"},{"key":"1103_CR8","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1002\/bjs.5338","volume":"93","author":"A Gil-Rendo","year":"2006","unstructured":"Gil-Rendo A, Zornoza G, Garcia-Velloso MJ, Regueira FM, Beorlegui C, Cervera M: Fluorodeoxyglucose positron emission tomography with sentinel lymph node biopsy for evaluation of axillary involvement in breast cancer. Br J Surg. 2006, 93: 707-712. 10.1002\/bjs.5338.","journal-title":"Br J Surg"},{"key":"1103_CR9","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1001\/archsurg.141.8.783","volume":"141","author":"A Chung","year":"2006","unstructured":"Chung A, Liou D, Karlan S, Waxman A, Fujimoto K, Hagiike M, Phillips EH: Preoperative FDG-PET for axillary metastases in patients with breast cancer. Arch Surg. 2006, 141: 783-8; discussion 788-9. 10.1001\/archsurg.141.8.783.","journal-title":"Arch Surg"},{"key":"1103_CR10","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1200\/JCO.2004.04.148","volume":"22","author":"RL Wahl","year":"2004","unstructured":"Wahl RL, Siegel BA, Coleman RE, Gatsonis CG: Prospective multicenter study of axillary nodal staging by positron emission tomography in breast cancer: a report of the staging breast cancer with PET Study Group. J Clin Oncol. 2004, 22: 277-285. 10.1200\/JCO.2004.04.148.","journal-title":"J Clin Oncol"},{"key":"1103_CR11","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1093\/annonc\/mdl425","volume":"18","author":"U Veronesi","year":"2007","unstructured":"Veronesi U, De Cicco C, Galimberti V, Fernandez J, Rotmensz N, Viale G, Spano G, Luini A, Intra M, Veronesi P, Berrettini A, Paganelli G: A comparative study on the value of FDG-PET and sentinel node biopsy to identify occult axillary metastases. Ann Oncol. 2007, 18: 473-478. 10.1093\/annonc\/mdl425.","journal-title":"Ann Oncol"},{"key":"1103_CR12","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1056\/NEJMra050276","volume":"354","author":"ME Juweid","year":"2006","unstructured":"Juweid ME, Cheson BD: Positron-emission tomography and assessment of cancer therapy. N Engl J Med. 2006, 354: 496-507. 10.1056\/NEJMra050276.","journal-title":"N Engl J Med"},{"key":"1103_CR13","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1007\/s00259-005-1835-7","volume":"33","author":"M Tatsumi","year":"2006","unstructured":"Tatsumi M, Cohade C, Mourtzikos KA, Fishman EK, Wahl RL: Initial experience with FDG-PET\/CT in the evaluation of breast cancer. Eur J Nucl Med Mol Imaging. 2006, 33: 254-262. 10.1007\/s00259-005-1835-7.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1103_CR14","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1007\/s00259-006-0066-x","volume":"33","author":"C Rousseau","year":"2006","unstructured":"Rousseau C, Bourbouloux E, Campion L, Fleury N, Bridji B, Chatal JF, Resche I, Campone M: Brown fat in breast cancer patients: analysis of serial (18)F-FDG PET\/CT scans. Eur J Nucl Med Mol Imaging. 2006, 33: 785-791. 10.1007\/s00259-006-0066-x.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1103_CR15","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/BF02967197","volume":"7","author":"M Ohta","year":"2000","unstructured":"Ohta M, Tokuda Y, Saitoh Y, Suzuki Y, Okumura A, Kubota M, Makuuchi H, Tajima T, Yasuda S, Shohtsu A: Comparative efficacy of positron emission tomography and ultrasonography in preoperative evaluation of axillary lymph node metastases in breast cancer. Breast Cancer. 2000, 7: 99-103.","journal-title":"Breast Cancer"},{"key":"1103_CR16","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/BF02967467","volume":"7","author":"H Hashimoto","year":"2000","unstructured":"Hashimoto H, Suzuki M, Oshida M, Nagashima T, Yagata H, Shishikura T, Imanaka N, Nakajima N: Quantitative ultrasound as a predictor of node metastases and prognosis in patients with breast cancer. Breast Cancer. 2000, 7: 241-246.","journal-title":"Breast Cancer"},{"key":"1103_CR17","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s10549-004-1478-6","volume":"89","author":"DO Watermann","year":"2005","unstructured":"Watermann DO, Tempfer CB, Hefler LA, Parat C, Stickeler E: Ultrasound criteria for ductal invasive breast cancer are modified by age, tumor size, and axillary lymph node status. Breast Cancer Res Treat. 2005, 89: 127-133. 10.1007\/s10549-004-1478-6.","journal-title":"Breast Cancer Res Treat"},{"key":"1103_CR18","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s11307-005-0013-4","volume":"7","author":"BJ Fueger","year":"2005","unstructured":"Fueger BJ, Weber WA, Quon A, Crawford TL, Allen-Auerbach MS, Halpern BS, Ratib O, Phelps ME, Czernin J: Performance of 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography and integrated PET\/CT in restaged breast cancer patients. Mol Imaging Biol. 2005, 7: 369-376. 10.1007\/s11307-005-0013-4.","journal-title":"Mol Imaging Biol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-8-165.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-8-165\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-8-165","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-8-165.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T06:43:25Z","timestamp":1630478605000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-8-165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6,9]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["1103"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-8-165","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,6,9]]},"assertion":[{"value":"25 December 2007","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2008","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2008","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"165"}}